Concentrics Research
  • RX-to-OTC
    Switch
  • Healthcare
    Market
    Research
  • Clinical
    Research
  • Our
    Research
    Facility
  • About Us
  • Divisions
  • Services
  • Contact Us

Current News and Events

Concentrics works with Alcon on successful switch of Pataday

Posted February 24th, 2020. Filed under Archives

Pataday switch announcement

Concentrics works with GSK on successful switch of Voltaren

Posted February 24th, 2020. Filed under Archives

https://www.fda.gov/news-events/press-announcements/fda-approves-three-drugs-nonprescription-use-through-rx-otc-switch-process

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Posted January 18th, 2019. Filed under Concentrics News
Tags: FDA, Naloxone, Pivotal Study

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

News & Events
Categories
  • Archives
  • Concentrics News
Concentrics Research Headquarters
9335 Delegates Row Indianapolis, IN 46240

Phone: 800.800.5525 Fax: 317.705.2175

Concentrics Research
Strategy Center
6 Campus Dr.
Parsippany, NJ 07054
 
Phone: 800.800.5525
Fax: 317.705.2175

Site Links
  • Home
  • Site map
  • Newsroom
  • About Us
  • Services
  • Contact Us
  • Terms of Use
  • Online Privacy Policy
  • Your Privacy Choices
Contact Us



    Enter Characters to the Right

    Web design by BoxCrush®